Authors
Loading...
Randomized trial reveals the complexities of treating hepatitis C and B virus coinfection, suggesting tailored therapies are essential for better outcomes.
Maqsood et al. (2023) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: